A Phase II Safety and Efficacy Study of Clarithromycin in the Treatment of Disseminated M. Avium Complex (MAC) Infections in Patients With AIDS
- Conditions
- HIV InfectionsMycobacterium Avium-intracellulare Infection
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2011-02-25
- Target Recruit Count
- 100
- Registration Number
- NCT00000644
- Locations
- 🇺🇸
Rush Presbyterian - Saint Luke's Med Ctr, Chicago, Illinois, United States
🇺🇸Univ of Southern California / LA County USC Med Ctr, Los Angeles, California, United States
🇺🇸Johns Hopkins Hosp, Baltimore, Maryland, United States
A Randomized, Double-Blind Study of 566C80 Versus Septra (Sulfamethoxazole/Trimethoprim) for the Treatment of Pneumocystis Carinii Pneumonia in AIDS Patients
- Conditions
- Pneumonia, Pneumocystis CariniiHIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2011-03-01
- Target Recruit Count
- 300
- Registration Number
- NCT00000655
- Locations
- 🇺🇸
Georgetown Univ Med Ctr, Washington, District of Columbia, United States
🇺🇸Univ of Cincinnati, Cincinnati, Ohio, United States
🇺🇸Veterans Administration Med Ctr, Washington, District of Columbia, United States
A Comparison of Nelfinavir Plus Saquinavir Plus Delavirdine or 3TC/ZDV Versus Nelfinavir Plus 3TC/ZDV in HIV-Infected Patients
- Conditions
- HIV Infections
- Locations
- 🇺🇸
Willow Clinic, Menlo Park, California, United States
🇺🇸Stanford Univ Med Ctr, Stanford, California, United States
🇺🇸Univ of Colorado Health Sciences Ctr, Denver, Colorado, United States
Comparing Single Photon Emission Computed Tomography (SPECT) and Liver Biopsy to Evaluate the Liver in Patients With HIV and Hepatitis C Virus
- Conditions
- HIV InfectionsHepatitis C
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2008-07-30
- Target Recruit Count
- 44
- Registration Number
- NCT00006643
- Locations
- 🇺🇸
Univ of Miami School of Medicine, Miami, Florida, United States
🇺🇸Univ of Hawaii, Honolulu, Hawaii, United States
🇺🇸Bellevue Hosp / New York Univ Med Ctr, New York, New York, United States
The Effects of Treatment for Mycobacterium Avium Complex (MAC) on the Cells of HIV-Infected Patients
- Conditions
- Mycobacterium Avium-Intracellulare InfectionHIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Target Recruit Count
- 24
- Registration Number
- NCT00000860
- Locations
- 🇺🇸
Division of Inf Diseases/ Indiana Univ Hosp, Indianapolis, Indiana, United States
🇺🇸Univ of Cincinnati, Cincinnati, Ohio, United States
🇺🇸Univ of Colorado Health Sciences Ctr, Denver, Colorado, United States
A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV (vCP205) and HIV-1 SF-2 rgp120 in HIV-1 Uninfected Volunteers to Evaluate Accelerated Vaccine Schedules
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-11-04
- Target Recruit Count
- 34
- Registration Number
- NCT00001076
- Locations
- 🇺🇸
UAB AVEG, Birmingham, Alabama, United States
🇺🇸Univ. of Rochester AVEG, Rochester, New York, United States
🇺🇸St. Louis Univ. School of Medicine AVEG, Saint Louis, Missouri, United States
A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia Derived HIV-1 Recombinant Envelope Glycoprotein (gp160) of Human Immunodeficiency Virus: Evaluation of Accelerated Schedules
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-11-04
- Target Recruit Count
- 30
- Registration Number
- NCT00000957
- Locations
- 🇺🇸
St. Louis Univ. School of Medicine AVEG, Saint Louis, Missouri, United States
🇺🇸JHU AVEG, Pittsburgh, Pennsylvania, United States
🇺🇸Vanderbilt Univ. Hosp. AVEG, Nashville, Tennessee, United States
A Placebo-Controlled, Phase I, Pilot Clinical Trial to Evaluate the Safety and Immunogenicity of ENV 2-3, a Yeast-Derived Recombinant Envelope Protein of Human Immunodeficiency Virus-1, in Combination With MTP-PE/MF59 in Individuals With HIV Infection (Placebo Patients Receive MF59 Emulsion Only)
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-11-04
- Target Recruit Count
- 8
- Registration Number
- NCT00000958
- Locations
- 🇺🇸
Univ. of Rochester AVEG, Rochester, New York, United States
A Phase I Clinical Trial to Evaluate: Part A. The Safety of MTP-PE/MF59 Adjuvant Emulsion. Part B. The Safety and Immunogenicity of Env 2-3, a Yeast Derived Recombinant Envelope Protein of Human Immunodeficiency Virus-1, in Combination With MTP-PE/MF59
- Conditions
- HIV InfectionsHIV Seronegativity
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-11-04
- Target Recruit Count
- 64
- Registration Number
- NCT00000972
- Locations
- 🇺🇸
UW - Seattle AVEG, Seattle, Washington, United States
🇺🇸Vanderbilt Univ. Hosp. AVEG, Nashville, Tennessee, United States
🇺🇸Univ. of Rochester AVEG, Rochester, New York, United States
Trimetrexate Plus Leucovorin Calcium Rescue Versus Sulfamethoxazole-Trimethoprim in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS
- Conditions
- HIV InfectionsPneumonia, Pneumocystis Carinii
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-11-04
- Target Recruit Count
- 302
- Registration Number
- NCT00001014
- Locations
- 🇺🇸
Washington U CRS, Saint Louis, Missouri, United States
🇺🇸Case CRS, Cleveland, Ohio, United States
🇺🇸Ucsf Aids Crs, San Francisco, California, United States